Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Alina Shapira, Yoav D. Livney, Henk J. Broxterman, et al.
Drug Resistance Updates (2011) Vol. 14, Iss. 3, pp. 150-163
Closed Access | Times Cited: 478

Showing 1-25 of 478 citing articles:

Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Fangqiong Tang, Linlin Li, Dong Chen
Advanced Materials (2012) Vol. 24, Iss. 12, pp. 1504-1534
Closed Access | Times Cited: 2608
New approaches and procedures for cancer treatment: Current perspectives
Dejene Tolossa Debela, Seke GY Muzazu, Kidist Digamo Heraro, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 960
Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
Ping Huang, Dali Wang, Yue Su, et al.
Journal of the American Chemical Society (2014) Vol. 136, Iss. 33, pp. 11748-11756
Closed Access | Times Cited: 684
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen, Tianlu Shi, Lei Zhang, et al.
Cancer Letters (2015) Vol. 370, Iss. 1, pp. 153-164
Closed Access | Times Cited: 671
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman, Arthur Rekechenetskiy, Eggehard Holler, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1866-1879
Open Access | Times Cited: 667
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che‐Ming Jack Hu, Liangfang Zhang
Biochemical Pharmacology (2012) Vol. 83, Iss. 8, pp. 1104-1111
Closed Access | Times Cited: 640
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Ke Chen, Yinghui Huang, Ji‐Long Chen
Acta Pharmacologica Sinica (2013) Vol. 34, Iss. 6, pp. 732-740
Open Access | Times Cited: 575
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Bivash Mandal, Himanshu Bhattacharjee, Nivesh Mittal, et al.
Nanomedicine Nanotechnology Biology and Medicine (2012) Vol. 9, Iss. 4, pp. 474-491
Closed Access | Times Cited: 432
Biogenesis of metal nanoparticles and their pharmacological applications: present status and application prospects
Pramila Khandel, Ravi Kumar Yadaw, Deepak Kumar Soni, et al.
Journal of nanostructure in chemistry (2018) Vol. 8, Iss. 3, pp. 217-254
Open Access | Times Cited: 392
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin, Jelena Grahovac, Anamaria Brozović, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100715-100715
Open Access | Times Cited: 388
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Qi Yin, Jianan Shen, Zhiwen Zhang, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1699-1715
Closed Access | Times Cited: 352
Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy
Vivek K. Chaturvedi, Anshuman Singh, Vinay K. Singh, et al.
Current Drug Metabolism (2018) Vol. 20, Iss. 6, pp. 416-429
Closed Access | Times Cited: 348
Odyssey of a cancer nanoparticle: From injection site to site of action
Joseph W. Nichols, You Han Bae
Nano Today (2012) Vol. 7, Iss. 6, pp. 606-618
Open Access | Times Cited: 347
Role of integrated cancer nanomedicine in overcoming drug resistance
Arun K. Iyer, Amit Singh, Srinivas Ganta, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1784-1802
Closed Access | Times Cited: 319
Nanopreparations to overcome multidrug resistance in cancer
Niravkumar R. Patel, Bhushan S. Pattni, Abraham H. Abouzeid, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1748-1762
Open Access | Times Cited: 318
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Mar Creixell, Nicholas A. Peppas
Nano Today (2012) Vol. 7, Iss. 4, pp. 367-379
Open Access | Times Cited: 309
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Maya Bar-Zeev, Yoav D. Livney, Yehuda G. Assaraf
Drug Resistance Updates (2017) Vol. 31, pp. 15-30
Closed Access | Times Cited: 286
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles
Chiranjeevi Peetla, Sivakumar Vijayaraghavalu, Vinod Labhasetwar
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1686-1698
Open Access | Times Cited: 250
Synergistic nanomedicine by combined gene and photothermal therapy
Jinhwan Kim, Jihoon Kim, Cherlhyun Jeong, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 99-112
Closed Access | Times Cited: 247
Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles
Limin Pan, Jianan Liu, Qianjun He, et al.
Biomaterials (2013) Vol. 34, Iss. 11, pp. 2719-2730
Closed Access | Times Cited: 241
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100682-100682
Open Access | Times Cited: 241
Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells
Kyoung-Ran Kim, Da-Rae Kim, Taemin Lee, et al.
Chemical Communications (2013) Vol. 49, Iss. 20, pp. 2010-2010
Closed Access | Times Cited: 234
Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
Sophie Taylor, Enrico P. Spugnini, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2015) Vol. 23, pp. 69-78
Closed Access | Times Cited: 227
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 227
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
Alberto Gabizón, Yogita P. Patil, Ninh M. La‐Beck
Drug Resistance Updates (2016) Vol. 29, pp. 90-106
Closed Access | Times Cited: 225
Page 1 - Next Page

Scroll to top